References
Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387–92.
Bode SF, Lehmberg K, Maul-Pavicic A, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012;14(3):213.
Schubert D, Bode C, Kenefeck R, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410–6.
Lo B, Zhang K, Lu W, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436–40.
Dalal RS, LeGolvan MP, Stachurski DR, Goldberg LR. Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy. Rhode Island Medical Journal. 2014;97(8):28–31.
Henter J-I, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367–73.
Frimmel S, Schipper J, Henschel J, et al. First description of single-pass albumin dialysis combined with cytokine adsorption in liver failure and hemophagocytic syndrome resulting from generalized herpes simplex virus 1 infection. Available at: http://cytosorb-therapy.com/wp-content/uploads/2016/06/Caseoftheweek_24_E_one_page.pdf
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was supported by the German Federal Ministry of Education and Research (BMBF 01EO1303) (to KW, BG). The authors are responsible for the contents of this publication.
Conflict of Interest
KW has received a research grant from BMS, honoraria for consultant services from LFB, and for speaking engagements from Octapharma and Baxalta. FR has received an educational grant and speaker honorarium from Pfizer. Our ICU team received technical support during the CytoSorbTM application by the supplier. CG, PLR, BG, and DD declare that they have no conflict of interest.
Additional information
Daniel Duerschmied and Klaus Warnatz contributed equally to this report.
Rights and permissions
About this article
Cite this article
Greil, C., Roether, F., La Rosée, P. et al. Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient. J Clin Immunol 37, 273–276 (2017). https://doi.org/10.1007/s10875-017-0377-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-017-0377-7